"When you're looking at manufacturers like Endo, where there are real allegations that they have been downplaying the risks, then the CDC guidelines will be terrific evidence," said Bill Curtis of the Curtis Law Group, which represents plaintiffs in pharmaceutical litigation. "Because now it's not just a plaintiff’s attorney saying that drug companies' marketing efforts underestimated the risks — now you have the CDC reinforcing what the risks are."